Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Chinese Journal of Contemporary Pediatrics ; (12): 1119-1126, 2021.
Article in English | WPRIM | ID: wpr-922399

ABSTRACT

OBJECTIVES@#To establish a predictive equation for commonly used pulmonary ventilation function parameters in children aged 6-<16 years in northeast China.@*METHODS@#A total of 504 healthy children from Liaoning, Jilin, and Heilongjiang provinces of China were selected for the prospective study, among whom there were 242 boys and 262 girls. The JAEGER MasterScreen Pneumo spirometer was used to measure pulmonary ventilation function. With the measured values of 10 parameters, including forced vital capacity (FVC), forced expiratory volume in 1 second (FEV@*RESULTS@#The boys aged 9-<10 years and 15-<16 years had significantly higher body height, FVC, and FEV@*CONCLUSIONS@#A new predictive equation for the main pulmonary ventilation function parameters has been established in this study for children aged 6-<16 years in northeast China, which provides a basis for accurate judgment of pulmonary function abnormalities in clinical practice.


Subject(s)
Child , Female , Humans , Male , China , Forced Expiratory Volume , Prospective Studies , Pulmonary Ventilation , Reference Values , Schools , Vital Capacity
2.
Acta Pharmaceutica Sinica ; (12): 488-491, 2007.
Article in English | WPRIM | ID: wpr-268612

ABSTRACT

Polysaccharide sulfate (PSS) is a new type of antiatherosclerotic medicine for its effects of anticoagulation, anti-thrombosis and modulation of dyslipidemia. However, it is still uncertain whether PSS could modulate the diabetic dyslipidemia or not. Here, the rat model of diabetic dyslipidemia was developed and the effects of PSS on glucose and lipid levels were investigated in this animal model. Wistar rats were iv injected with streptozotocin 20 mg x kg(-1) after feeding with high fat diet for one and a half month. Then, rats received orally PSS (30, 90, and 180 mg x kg(-1)) for 1 month. After oral treatment with PSS (90 and 180 mg x kg(-1)) for 1 month, the levels of triglyceride (TG), total cholesterol (TC), low density lipoprotein-cholesterol (LDL-C) were significantly reduced and the level of high density lipoprotein-cholesterol (HDL-C) increased, compared with diabetic control rats. Moreover, PSS (30, 90, and 180 mg x kg(-1)) had a tendency to reduce glucose and insulin levels, and significantly increased insulin sensitivity index. Our results suggest that PSS could improve insulin sensitivity and relieve dyslipidemia in diabetic dyslipidemic rats.


Subject(s)
Animals , Male , Rats , Administration, Oral , Blood Glucose , Metabolism , Cholesterol, HDL , Blood , Cholesterol, LDL , Blood , Diabetes Mellitus, Experimental , Blood , Dyslipidemias , Blood , Hypolipidemic Agents , Pharmacology , Insulin , Blood , Insulin Resistance , Polysaccharides , Pharmacology , Random Allocation , Rats, Wistar , Streptozocin , Sulfates , Pharmacology , Triglycerides , Blood
SELECTION OF CITATIONS
SEARCH DETAIL